Core-binding factor β (Cbfβ) expression in bone marrow Adipoq+ cells (BMACs) — a specialized marrow adipocyte population — declines with age in both mice and humans, triggering skeletal stem and progenitor cell (SSPC) depletion, impaired fracture healing, and a damaging senescence-associated secretory phenotype (SASP). Multi-omics analysis (RNA-seq, CUT&Tag, ATAC-seq) pinpoints the mechanism: Cbfβ maintains chromatin accessibility at DNA repair loci, preserving genomic stability in BMACs. When lost, BMACs senesce and poison the local niche, collapsing SSPC populations. AAV-mediated Cbfβ restoration in aged mice rescued both SSPC numbers and bone repair capacity.
This finding reframes marrow adipocytes — long dismissed as passive filler — as active guardians of the skeletal stem cell niche. The SASP link is particularly important: it connects bone aging to the broader senescence biology field, suggesting that declining Cbfβ may be one upstream node driving the inflammatory microenvironment implicated in multiple age-related tissue failures. The senolytic intervention (clearing senescent BMACs) restoring SSPCs adds practical resonance, given that senolytics like dasatinib/quercetin are already in human trials. Limitations are real: this remains largely a mouse study with only correlational human data, and AAV delivery to marrow adipocytes poses translational hurdles. Still, identifying a single transcription factor whose decline causally collapses a stem cell niche — and showing rescue via gene therapy — elevates this above incremental work. It is a mechanistically rigorous, potentially paradigm-shifting contribution to skeletal aging biology.
